Sun Pharmaceutical Industries Ltd
BSE:524715
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sun Pharmaceutical Industries Ltd
BSE:524715
|
IN |
|
P
|
PIK Spetsializirovannyi Zastroyshchik PAO
MOEX:PIKK
|
RU |
|
Sir Shadi Lal Enterprises Ltd
BSE:532879
|
IN |
|
K
|
Kinder Morgan Inc
XMUN:2KD
|
US |
|
E
|
EBOS Group Ltd
F:EJG
|
AU |
|
A
|
Axos Financial Inc
SWB:BB4
|
US |
|
FIRST BANK (Hamilton)
NASDAQ:FRBA
|
US |
|
B
|
Biogen Inc
SGO:BIIB
|
US |
|
Singapore Airlines Ltd
SGX:C6L
|
SG |
|
A
|
Antofagasta PLC
OTC:ANFGF
|
UK |
|
J
|
Jervois Global Ltd
XTSX:JRV
|
AU |
Wall St Price Targets
SUNPHARMA Price Targets Summary
Sun Pharmaceutical Industries Ltd
According to Wall Street analysts, the average 1-year price target for SUNPHARMA is 2 086.42 INR with a low forecast of 1 664.54 INR and a high forecast of 2 481.38 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUNPHARMA's stock price target?
Price Target
2 086.42
INR
According to Wall Street analysts, the average 1-year price target for SUNPHARMA is 2 086.42 INR with a low forecast of 1 664.54 INR and a high forecast of 2 481.38 INR.
What is the Revenue forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 4 years is 13%.
What is the Gross Profit forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 4 years is 12%.
What is the Operating Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 4 years is 14%.
What is the Pre-Tax Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 15%.
What is the Net Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 4 years is 13%.
